Read More
Large-Cap Injectable-Focused Pharma Company Gains USFDA Nod for Key Pain Ma...
With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The co...
Articles of Gland%20Pharma%20Ltd
With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The co...
Copyright 2025 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)